Table 2.

The detailed description of EUS-guided laser ablation for tumors.

											CEA (ng/ml)		AFP (ng/mL)		CA19–9 (U/ml)			CA12–5 (U/ml)
Ablation area (cm)Pre-ablation	1st month	3rd month	Last month	Number of fibers (sessions)	Type of needle	Power (W)	Energy (J)	Ablation time (min)	Prognosis	Complication/Outcome	Before	After	Before	After	Before	After	Before		After
MR 3.4*2.7; CEUS 2.2*1.7	MR 3.8*3.2	MR 3.5*2.6	MR 3.1*2.2	1(2)	22G	5W	3600	32(12)	CR	Alive	NA	2.5	3524.7	1671	NA	105.2	NA		NA
MR 2.1*1.9	CEUS 2.5*2.2	MR 2.1*1.7	MR 1.5*0.7	1(3)	22G	5W	11950	58(40)	CR	Alive	9.5		19.1	13.4	NA	6.2	12.7		NA
MR 1.6*1.3; CEUS 1.4*1.0	CT 1.6*1.4		MR 2.7*1.5	1	22G	5W	5200	38(17)	CR	Mild nausea/alive	3.5	2.7	109.2	4.5	NA	20.8	8.5		NA
MR 1.1*1.0	MR 1.4*1.5		MR 0.9*0.7	1	22G	5W	1800	26(6)	CR	Alive	5.3	4	25.7	6.3	7.6	2.5	8.4		11.2
MR 1.2*1.1; CEUS 1.3*1.2	MR 1.6*1.0		MR 1.4*1.2	1	22G	5W	1200	25(4)	CR	Alive	1.6	1.7	2	11.2	20.8	2.5	14.5		15.0
MR 0.9*0.7	MR 1.3*0.8		MR 0.7*0.3	1	22G	5W	1600	26(6)	CR	Alive	1.4	2.6	81.8	6.6	6.2	53.2	15.1		13.2
CEUS 1.3*1.2; MR 1.8*1.5			Disappear in MR	1	22G	5W	1500	25(5)	CR	Alive	2.7	3.3	47.1	<2	<2	32.3	11.2		13.7
US 2.1*1.9; MR 2.2*1.9		MR 2.1*1.5	MR 1.4*1.3	1	22G	5W	1200	26(4)	CR	Alive	5.2	11.9	2.2	2.1	34.2	34	34.2		8.9
CEUS 1.9*1.8	MR 1.8*1.3		Disappear in MR	1(2)	22G	5W	1500	25(5)	CR	Alive	3.3	4.2	31.4	7.8	8.2	47	40.2		16
US 3.0*2.7	MR 4.0*3.1			1(2)	22G	5W	2800	30(10)	CR	Alive	1.4	1.42	7.8	3.9	12.1	4.45	4		8.1

MR: Magnetic resonance;

CT: Computed tomography;

CEUS: Contrast-enhanced ultrasonography;

US: ultrasonography;

CR: Complete response;

AFP: Alpha fetal protein;

CA19–9: Carbohydrate antigen 19–9;

CA12–5: Carbohydrate antigen 12–5;

CEA: Carcinoembryonic antigen;

NA: Not available.